Qfitlia approval in India marks a significant advancement in pharma solutions.
Month: October 2026
Cancer drug prices are set to drop significantly as the government caps trade margins.
Bajaj Healthcare acquisition is set to transform the pharmaceutical landscape with NCLT approval.
Cancer drug prices are set to decrease by up to 70% in India, making...
Drug price control is essential for affordable healthcare. Discover proven strategies to enhance savings...
Jagsonpal Pharmaceuticals acquisition offers insights into strategic growth in the wellness sector.
